Literature DB >> 15080976

Biaryl amide glucagon receptor antagonists.

Ravi Kurukulasuriya1, Bryan K Sorensen, James T Link, Jyoti R Patel, Hwan-Soo Jae, Marty X Winn, Jeffrey R Rohde, Nelson D Grihalde, Chun W Lin, Christopher A Ogiela, Andrew L Adler, Christine A Collins.   

Abstract

Biaryl amides derived from a reported series of ureas 1 were evaluated and found to be potent human glucagon receptor antagonists. The benzofuran analogue 6i was administered in Sprague-Dawley rats and blocked the effects of an exogenous glucagon challenge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080976     DOI: 10.1016/j.bmcl.2004.02.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Evaluate neuroprotective effect of silibinin using chronic unpredictable stress (cus) model.

Authors:  Devala Rao Garikapati; Praveen Begum Shaik; Hanumanthu Penchalaiah
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-12-25

2.  Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus.

Authors:  Mohamed Lotfy; Huba Kalasz; Gyorgy Szalai; Jaipaul Singh; Ernest Adeghate
Journal:  Open Med Chem J       Date:  2014-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.